



Despite the progress of medi-
cine and the utilisation of the mod-
ern medicines products, treatment 
of diabetic ulcers is not often ac-
companied by satisfactory results. 
The number of patients with dia-
betes is rapidly increasing around 
the world. A large percentage of 
this population can be expected to 
develop diabetic ulcers. The eco-
nomic, social, and public health 
burden of these ulcers is immense. 
This problem is tackled every day 
by many healthcare workers all 
over the world [1]. Patients with 
diabetic leg ulcer have a greater 
than twofold increase in mortality 
compared with nonulcerated dia-
betic patients [2]. 
The outcome of management 
of diabetic leg ulcers remains a 
challenge, and there remains con-
tinuing uncertainty concerning 
optimal approaches to manage-
ment [3]. Cilostazol is one of the 
preparations that finds out vasodi-
late and antithrombotic properties. 
The efficiency of application of ci-
lostazol at the chronic ischemia 
of legs, intermittent claudication 
is confirmed by evidential med-
icine [4]. Own experience of us-
ing this preparation testifies about 
perspective of its application for 
patients with the diabetic leg ulcers 
[5, 6]. Expediency of its application 
for patients with the diabetic leg 
ulcers needs profound confirma-
tion, although there are reports 
that specify on credible potential of 
the use of preparation at treatment 
of this category of patients [7, 8].
The research was conduct-
ed for the purpose of improving 
treatment outcomes, reducing 
time on treatment, declining in 
disability, improving life quality 
of patients with diabetic ulcers.
3. Materials and Methods
The research was executed at the Department of surgery 
No. 2 of Danylo Halytsky Lviv National Medical University, 
based on the Department of Surgery No. 1 and the Department 
of Vascular Surgery of the Lviv Regional Hospital during 2016–
2017. The analysis of the treatment effectiveness in patients with 
diabetic lower extremity ulcers was conducted. Wounds were 
concidered as a chronic (nonhealing) if the positive dynamics 
was not observed or its changes were minimally expressed 
after four weeks of treatment [9]. The inclusion criteria for the 
study were chronic diabetic leg ulcers not less than 25 cm2, 
preliminary treatment and lack of its positive dynamics. In this 
research two groups of patients were used: I group (51 patients) 
– treated with a standard procedure (control group) and second 
group (52 patients) – whether 
treatment was supplemented cy-
tostazol (100 mg twice a day). 
The rate of the wound healing 
was calculated by the formula 
[10]. The first measurement was 
conducted after necrectomy, 
measurement was repeated after 
14 days of the first one. The av-
erage size of ulcers was 114 cm2 
(26–688 cm2). For the evaluation 
the life quality of patients and its 
changes a questionnaire «SF – 36 
Health Status Survey» was used 
during the treatment [11].
Exclusionary criteria were 
cancer, severe concomitant dis-
eases, and lesions of osteoarticu-
lar apparatus.
Statistical analysis of the pre-
sented data was performed using 
Student̀ s T-test. Differences be-
tween mean values were conci-
dered significant if the probabili-
ty was at least 95 % (p <0.05). 
For this research 120 histo-
logical preparations were ana-
lyzed (20 patients of each group). 
All patients gave their consent 
to participate in this research. 
Tissue samples for histological 
preparations were taken from the 
most visually healthy areas of the 
wound before treatment, after 
two and four weeks of treatment. 
Tissues dissected with blade 
and entire piece was taken on 
the border of the skin and the 
wound surface (fragment size: 
1×0,5×0,5 cm). Fixation of tis-
sue samples was performed in 
4 % neutral formalin. Histologi-
cal preparations were stained with 
hematoxylin and eosin. In order 
to clarify the fundamental mech-
anisms of regenerative processes 
in the patient of control group 
and ones who used cilostazol ad-
ditionally the lectins histochemical investigation was performed 
using lectins of different carbohydrate specificity labeled per-
oxidase. Lectins were produced in the laboratory «Lectintest» 
(Danylo Halytsky Lviv National Medical University). Lectins 
panel includes: Con A – specific to DMan, HPA – to NAcDGal, 
PNA – to βDGal, LABA – to αLFuc, SBA – to NAcDGal, WGA – 
to NAcDGlc. Visualization of lectin receptors was carried out 
in the system H2O2-3’3’-diaminobenzidine tetrahydro chlo-
ride[12,13]. Microscopic examination of histological prepa-
rations was performed using a microscope Olympus BX-41, 
and Carl ZEISS Jena Ng with digital camera Canon IXUS 700.
4. Results
The quality of life questionnaire «SF - 36 Health Status Survey» 
was used in order to evaluate the effectiveness of cilostazol before 
and after four weeks of the treatment. After analysing the ques-
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tionnaire results, significant differences were observed between 
groups of patients, manifested by de-emphasized role of physical 
problems, improved viability and psycho-emotional state with less 
manifestation of the differences in the control group (Table 1).
Table 1
Evaluation of the quality of life of patients with diabetic ulcers 
using questionnaire «SF – 36 Health Status Survey» (in points)
Quality of life: 
SF-36 











Physical activity 25.2±3.4 54.0±5.2* 25.4±.9 60.8±5.4*
Role of physical 
problems 16.6±3.0 33.9±3.6* 16.4±2.5 45.5±4.2*
 Δ
Pain 42.4±3.9 61.4±5.8* 43.1±4.0 72.0-±5.9*
General health 31.0±3.1 42.4±3.8* 31.2±3.0 53.3±4.4*
Viability 18.1±2.0 31.8±3.2* 18.0±2.2 42.9±4.1* Δ
Social activity 12.0±1.8 37.1±3.6* 12.1±1.7 43.9±4.2*
Role of emotional 
problems 11.1±2.2 40.2±4.1* 11.2±2.1 52.8±4.9*
 Δ
Mental health 21.4±2.0 43.0±3.9* 21.6±2.9 55.0±4.8* Δ
Note: * – reliability in relation to the initial level (p<0.05); Δ – reliability 
in relation to the control group (p<0.05)
Based on the calculation relative rate of wound healing in 
groups was established: a control group – (0.253±0.020) %/day; 
+cilostazol – (0.331±0.024) % /day (p<0.05). 
Histologically it was found that thickening of epidermis, 
epithelial vacuolization of the germ layer of epidermis were 
peculiar to diabetic ulcers before treatment. Fibrin region in the 
papillary dermis, stasis in blood vessels, swelling around blood 
vessels and hemorrhage were observed. Disturbances of micro-
circulatory was noted and as a result – degenerative changes 
of fibrous structures around the vessels. Desquamation of the 
surface layer of epidermis was reported.
Lectin-histochemical research have shown that before the 
treatment of patients with diabetic ulcers, a positive reaction 
with Con A in thick bundles of collagen fibers of reticular dermis 
against the background of weak binding of thin bundles of colla-
gen fibers can be stated. There is also high expression in mannose 
glycans in local groups of white blood cells and the basal layer of 
the epidermis, epitheliocytes of germinal layer of the epidermis 
and the minor one in the nuclei of the surface layers.
Mosaicity of the receptors’ binding of mannose specific 
lectin Con A with bundles of collagen fibers or their loss by 
the last may indicate their degradation in the areas of inflam-
mation. High expression of mannose glycans in the cells of 
the Leukocyte infiltrates indicates that they are involved in 
the synthesis of pro-inflammatory interleukins. After 14 days 
of treatment, weak binding of Con A with collagen fibers of 
the dermis was observed. Meanwhile, emergence of mannose 
glycans in endotheliocytes of newly formed vessels of micro-
circulation circle and their slight expression in elastic fibers 
is noted. After 28 days of treatment a moderate expression 
of mannose glycans was observed in the bundles of collagen 
fibers, and high expression in endothelium of vessels of micro-
circulation circle and cellular elements of connective tissue - 
fibroblasts was also observed. Along with the above mentioned 
process, high expression of mannose glycans in germinal layer 
of epidermis was stated which may indicate that mannose 
glycans are involved in proliferative and adhesion processes. 
During the promotion of epithelial cells to the surface of the 
epidermis, in the cytoplasm of the last the number of receptors 
Con A is decreased. In the papillary layer of dermis a high 
expression of mannose glycans in the cells of fibroblastic row 
is observed which indicates the increase of synthetic processes 
in them involving mannose glycans.
NAcDGal-receptors of the specific lectin HPA before treat-
ment were observed in the areas of necrosis of reticular dermis 
and cellular detritus. Weak expression of lectin receptors HPA is 
observed in degraded fibrous structures. After 14 days the weak 
binding of lectin with the fragments of collagen fibers of the retic-
ular dermis layer was diagnosed. After 28 days of treatment, a local 
strengthening of HPA lectin receptors with collagen fibers was 
observed which indicates a partial recovery of bundles of collagen 
fibers since it is known that carbohydrate determinants are in-
volved in merger of collagen fibrils into collagen fibers. Before the 
treatment, mosaicity of αL-Fuc specific lectin LABA expression in 
degraded fibrous structures and cell detritus was also mentioned. 
On the 14th day of treatment a weak binding of lectin with elastic 
fibers in the area of the partial restoration of the dermis was ob-
served. Probably on the background of partial regeneration of the 
dermis there are areas of degraded collagen fiber bundles with the 
advent of low-positive LABA cells of fibroblastic row. On the 28th 
day the emergence of carbohydrate determinants in organized 
bundles of collagen fibers and germinal layer of the epidermis was 
observed. A similar binding specificity on the studied stages was 
noted with the lectins SBA, WGA and PNA.
6. Discussion
It was observed substantial positive changes in the state of 
patients who took cilostazol that was represented by the increase 
of the level of the quality of life. The reliable increase in the rate 
of wound healing was found in patients with diabetic ulcers who 
took cilostazol.
The lectin-histochemical research indicates that carbohy-
drate determinants as αD-man, βDGal and to a lesser extent, 
L-Fuc, NAcDGal, NAcDGlc are involved in the regeneration 
process of both the epidermis and dermis. A significant differ-
ence was detected on the 14th day of treatment. Evidence of this 
is the appearance of carbohydrate determinants in the endothe-
lium of newly formed blood vessels after two weeks of treatment 
while in the most of the patients’ drugs of the control group 
there were no such obvious manifestations of regeneration. 
Regarding the results of the research, cilostazol is worth to 
be examined as perspective means for treatment of patients with 
diabetic ulcers. In turn, the results of lectinohistochemicals re-
searches can be one of the objective tests of violation of balance 
of restorative-reparatory and destructively-necrotizing process-
es for patients with the ulcers of feet that respond to treatment 
in difficult way and can be applied for prognostication of effi-
ciency of the treatment.
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